Sonoma Pharmaceuticals (SNOA)
(Delayed Data from NSDQ)
$0.42 USD
+0.12 (37.34%)
Updated Jul 22, 2024 03:59 PM ET
After-Market: $0.42 0.00 (-0.71%) 6:38 PM ET
1-Strong Buy of 5 1
F Value C Growth A Momentum D VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SNOA 0.42 +0.12(37.34%)
Will SNOA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SNOA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNOA
Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum
Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Momentum But Is Still a Bargain Stock
SNOA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SNOA
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Sonoma Pharmaceuticals price target lowered by $1.75 at Ladenburg, here's why
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session